These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 31181727)

  • 101. Molecular Subtypes of Prostate Cancer.
    Arora K; Barbieri CE
    Curr Oncol Rep; 2018 Jun; 20(8):58. PubMed ID: 29858674
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients.
    Komiya A; Yasuda K; Watanabe A; Fujiuchi Y; Tsuzuki T; Fuse H
    Mol Clin Oncol; 2013 Mar; 1(2):257-262. PubMed ID: 24649157
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts.
    Adisetiyo H; Liang M; Liao CP; Jeong JH; Cohen MB; Roy-Burman P; Frenkel B
    J Cell Physiol; 2014 Sep; 229(9):1170-6. PubMed ID: 24752784
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis.
    Li S; Kang Y; Zeng Y
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189033. PubMed ID: 38040267
    [TBL] [Abstract][Full Text] [Related]  

  • 105. RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
    Labrecque MP; Brown LG; Coleman IM; Lakely B; Brady NJ; Lee JK; Nguyen HM; Li D; Hanratty B; Haffner MC; Rickman DS; True LD; Lin DW; Lam HM; Alumkal JJ; Corey E; Nelson PS; Morrissey C
    Cancer Res; 2021 Sep; 81(18):4736-4750. PubMed ID: 34312180
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Hypoxia induced cancer stem cell enrichment promotes resistance to androgen deprivation therapy in prostate cancer.
    O'Reilly D; Johnson P; Buchanan PJ
    Steroids; 2019 Dec; 152():108497. PubMed ID: 31521707
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer.
    Ehsani M; David FO; Baniahmad A
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810413
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages.
    Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):127-135. PubMed ID: 31439889
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.
    Federer-Gsponer JR; Müller DC; Zellweger T; Eggimann M; Marston K; Ruiz C; Seifert HH; Rentsch CA; Bubendorf L; Le Magnen C
    Prostate; 2020 Sep; 80(13):1108-1117. PubMed ID: 32628318
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Role of extracellular vesicles in castration-resistant prostate cancer.
    Liao C; Huang Z; Liu J; Deng M; Wang L; Chen Y; Li J; Zhao J; Luo X; Zhu J; Wu Q; Fu W; Sun B; Zheng J
    Crit Rev Oncol Hematol; 2024 May; 197():104348. PubMed ID: 38588967
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
    Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X
    J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer.
    Moll JM; Teubel WJ; Erkens SE; Jozefzoon-Agai A; Dits NF; van Rijswijk A; Jenster GW; van Weerden WM
    Front Oncol; 2022; 12():877613. PubMed ID: 35769712
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Characterization of Novel Progression Factors in Castration-Resistant Prostate Cancer Based on Global Comparative Proteome Analysis.
    Na AY; Choi S; Yang E; Liu KH; Kim S; Jung HJ; Choe Y; Ha YS; Kwon TG; Lee JN; Lee S
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298646
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Citrus Flavone Tangeretin Inhibits CRPC Cell Proliferation by Regulating Cx26, AKT, and AR Signaling.
    Zhang N; Wu W; Huang Y; An L; He Z; Chang Z; He Z; Lai Y
    Evid Based Complement Alternat Med; 2022; 2022():6422500. PubMed ID: 35111229
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer.
    Wen S; Niu Y; Huang H
    Asian J Urol; 2020 Jul; 7(3):203-218. PubMed ID: 33024699
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Clinical relevance of androgen receptor alterations in prostate cancer.
    Jernberg E; Bergh A; Wikström P
    Endocr Connect; 2017 Nov; 6(8):R146-R161. PubMed ID: 29030409
    [TBL] [Abstract][Full Text] [Related]  

  • 117. LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.
    Liang Y; Ahmed M; Guo H; Soares F; Hua JT; Gao S; Lu C; Poon C; Han W; Langstein J; Ekram MB; Li B; Davicioni E; Takhar M; Erho N; Karnes RJ; Chadwick D; van der Kwast T; Boutros PC; Arrowsmith CH; Feng FY; Joshua AM; Zoubeidi A; Cai C; He HH
    Cancer Res; 2017 Oct; 77(20):5479-5490. PubMed ID: 28916652
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Targeting ADT-Induced Activation of the E3 Ubiquitin Ligase Siah2 to Delay the Occurrence of Castration-Resistant Prostate Cancer.
    Yan T; Zhou D; Shi Y; Cui D; Jiang J; Han B; Xia S; Wang Z; Liu H; Guo W; Jing Y
    Front Oncol; 2021; 11():637040. PubMed ID: 33937036
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Functional analysis of GCNT3 for cell migration and EMT of castration-resistant prostate cancer cells.
    Yamamoto D; Sasaki K; Kosaka T; Oya M; Sato T
    Glycobiology; 2022 Sep; 32(10):897-908. PubMed ID: 35867813
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer.
    Zhou T; Feng Q
    Front Med (Lausanne); 2022; 9():924087. PubMed ID: 35966880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.